DK2217220T3 - Sammensætning af liponsyrepellets - Google Patents

Sammensætning af liponsyrepellets

Info

Publication number
DK2217220T3
DK2217220T3 DK08840866.1T DK08840866T DK2217220T3 DK 2217220 T3 DK2217220 T3 DK 2217220T3 DK 08840866 T DK08840866 T DK 08840866T DK 2217220 T3 DK2217220 T3 DK 2217220T3
Authority
DK
Denmark
Prior art keywords
lipoic acid
composition
acid pellets
pellets
active ingredients
Prior art date
Application number
DK08840866.1T
Other languages
English (en)
Inventor
Paolo Magri
Antonio Nardi
Annibale Salvi
Flavio Villani
Original Assignee
Laboratorio Chimico Int Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Chimico Int Spa filed Critical Laboratorio Chimico Int Spa
Application granted granted Critical
Publication of DK2217220T3 publication Critical patent/DK2217220T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Medicinal Preparation (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK08840866.1T 2007-10-23 2008-10-23 Sammensætning af liponsyrepellets DK2217220T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002051A ITMI20072051A1 (it) 2007-10-23 2007-10-23 Composizione a base di pellet di acido lipoico
PCT/IB2008/002835 WO2009053824A1 (en) 2007-10-23 2008-10-23 Lipoic acid pellet composition

Publications (1)

Publication Number Publication Date
DK2217220T3 true DK2217220T3 (da) 2011-08-01

Family

ID=40313864

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08840866.1T DK2217220T3 (da) 2007-10-23 2008-10-23 Sammensætning af liponsyrepellets

Country Status (27)

Country Link
US (1) US9820948B2 (da)
EP (1) EP2217220B1 (da)
JP (1) JP5626890B2 (da)
KR (1) KR101599078B1 (da)
CN (1) CN101861144B (da)
AT (1) ATE506053T1 (da)
AU (1) AU2008315667B2 (da)
BR (1) BRPI0816587A2 (da)
CA (1) CA2703152C (da)
CY (1) CY1112122T1 (da)
DE (1) DE602008006454D1 (da)
DK (1) DK2217220T3 (da)
ES (1) ES2363880T3 (da)
HR (1) HRP20110453T1 (da)
IL (1) IL205211A (da)
IT (1) ITMI20072051A1 (da)
MX (1) MX2010004481A (da)
NZ (1) NZ584884A (da)
PL (1) PL2217220T3 (da)
PT (1) PT2217220E (da)
RS (1) RS51712B (da)
RU (1) RU2501558C2 (da)
SI (1) SI2217220T1 (da)
TN (1) TN2010000163A1 (da)
UA (1) UA100394C2 (da)
WO (1) WO2009053824A1 (da)
ZA (1) ZA201002777B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
WO2011099031A1 (en) 2010-02-11 2011-08-18 Zota Health Care Limited Active antioxidants for all age group
GB201006200D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
US20130045273A1 (en) * 2011-08-19 2013-02-21 John Cuomo Methods for using nutritional supplements containing lipoic acids and sulfur containing compounds
CA2965671A1 (en) 2014-10-24 2016-04-28 Robert Shorr Methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndrome
WO2018111060A1 (es) * 2016-12-14 2018-06-21 Cidat, S.A. De C.V. Combinaciones y métodos para el tratamiento de dolor neuropático
CN106729725A (zh) * 2017-03-21 2017-05-31 北京百慧生化制药有限责任公司 硫辛酸作为抗氧化剂在多烯酸乙酯制剂或蛹油α‑亚麻酸乙酯制剂中的应用
WO2023199241A1 (en) * 2022-04-12 2023-10-19 URIACH ITALY S.r.l. Composition comprising lipoic acid, vitamin d and glutathione, uses thereof, and pharmaceutical and nutraceutical compositions thereof
IT202200007232A1 (it) * 2022-04-12 2023-10-12 Uriach Italy S R L Composizione comprendente acido lipoico, vitamina d e glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0774166B2 (ja) * 1987-02-06 1995-08-09 信越化学工業株式会社 徐放性被覆薬剤の製造方法
US6197340B1 (en) * 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
US6479069B1 (en) 1999-09-23 2002-11-12 Juvenon, Inc. Nutritional supplement for increased energy and stamina
WO2002036202A2 (en) * 2000-11-02 2002-05-10 Nutrition 21, Inc. Methods and compositions for the improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes and alpha lipoic acid
ITMI20012732A1 (it) * 2001-12-20 2003-06-20 Health Pharma S R L Integratore alimentare per neuropatici
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
EP1558244A2 (en) 2002-11-07 2005-08-03 DSM IP Assets B.V. Novel nutraceutical compositions comprising epigallocatechin gallate
US7387793B2 (en) * 2003-11-14 2008-06-17 Eurand, Inc. Modified release dosage forms of skeletal muscle relaxants
US20050181047A1 (en) * 2004-02-18 2005-08-18 Jaime Romero Compositions and methods for timed release of water-soluble nutritional supplements
WO2006089211A2 (en) 2005-02-17 2006-08-24 Premier Micronutrient Corporation Combat/training antioxidant micronutrient formulation and method of administration
JP2006298831A (ja) * 2005-04-21 2006-11-02 Sumitomo Shoji Chemicals Co Ltd αリポ酸粉体被覆物及びその製造方法、並びにαリポ酸含有食品
JP5157001B2 (ja) * 2005-04-30 2013-03-06 ビーエイチエヌ株式会社 安定化α−リポ酸組成物及びその利用
US20060270625A1 (en) * 2005-05-13 2006-11-30 Eastern Virginia Medical School Nutraceuticals for the treatment of neuropathy
JP5085329B2 (ja) * 2005-09-12 2012-11-28 協和発酵バイオ株式会社 α−リポ酸含有組成物
CN101394842B (zh) * 2006-04-26 2011-09-21 Dpi溶液株式会社 在水相中稳定的α硫辛酸胶囊组合物及制备该组合物的方法
ITMI20061024A1 (it) * 2006-05-25 2007-11-26 Eurand Pharmaceuticals Ltd Pellet a base di acido lipoico

Also Published As

Publication number Publication date
RS51712B (en) 2011-10-31
RU2010120706A (ru) 2011-11-27
NZ584884A (en) 2011-11-25
ITMI20072051A1 (it) 2009-04-24
UA100394C2 (en) 2012-12-25
CA2703152C (en) 2016-02-23
SI2217220T1 (sl) 2011-06-30
JP5626890B2 (ja) 2014-11-19
TN2010000163A1 (en) 2011-11-11
CN101861144B (zh) 2013-03-13
CN101861144A (zh) 2010-10-13
PL2217220T3 (pl) 2011-09-30
US20110129442A1 (en) 2011-06-02
AU2008315667A1 (en) 2009-04-30
DE602008006454D1 (de) 2011-06-01
ES2363880T3 (es) 2011-08-18
KR101599078B1 (ko) 2016-03-02
AU2008315667B2 (en) 2013-02-28
MX2010004481A (es) 2010-08-02
BRPI0816587A2 (pt) 2015-03-03
US9820948B2 (en) 2017-11-21
WO2009053824A1 (en) 2009-04-30
CY1112122T1 (el) 2015-11-04
ZA201002777B (en) 2011-06-29
ATE506053T1 (de) 2011-05-15
KR20100089848A (ko) 2010-08-12
IL205211A0 (en) 2010-12-30
IL205211A (en) 2013-01-31
EP2217220B1 (en) 2011-04-20
JP2011500784A (ja) 2011-01-06
CA2703152A1 (en) 2009-04-30
RU2501558C2 (ru) 2013-12-20
PT2217220E (pt) 2011-07-13
HRP20110453T1 (hr) 2011-07-31
EP2217220A1 (en) 2010-08-18

Similar Documents

Publication Publication Date Title
DK2217220T3 (da) Sammensætning af liponsyrepellets
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
UA107791C2 (en) Pesticidal compositions
BRPI0909084A2 (pt) Composição líquida, e, composto de peptídeo.
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
UY33397A (es) Forma sólida de un naftaleno carboxamida
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0812354A2 (pt) Composição farmacêutica não-aquosa.
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
ATE555156T1 (de) Sauerstofffänger-mischungen
EA201100286A1 (ru) Композиция кветиапина
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
DK2478054T3 (da) Polyamidsammensætning, som indeholder polyamid 4,10
ECSP10010491A (es) Composiciones fungicidas con 3'-bromo-2,3,4,6'-tetrametoxi-2',6-dimetilbenzofenona
ATE510900T1 (de) Reversible thermochrome zusammensetzungen
DK2219662T3 (da) Aktive, opløselige, post-translationelt modificerede neuregulin- isoformer.
CR20120521A (es) Combinaciones de principios activos
CL2012001159A1 (es) Composicion que comprende un inhibidor de alfa-1-proteinasa (api), y como minimo, un aminoacido; kit que comprende dicha composicion que se utiliza como una composicion farmaceutica adecuada para administracion intravenosa.
FR2923713B1 (fr) Composition reductrice epaissie.
BRPI0906343A2 (pt) composições de pentafluoretano, tetraflueoretano e n-butano.
BR112012002311A2 (pt) composto, composição farmacêutica, e, uso do composto.
FR2902783B1 (fr) Compositions pyrotechniques thermo-initiables, utilisation.
CL2012002986A1 (es) Extensor para una composicion de tinta que comprende almidon de papa, mono-estanol amina y solucion de resina; y mezcla de composicion de tinta.
ATE556446T1 (de) Batterieanoden
BRPI0816810A2 (pt) utilização de pelo menos um composto, e, composto.